ADAPY
Adaptimmune Therapeutics plc
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.03
■ 0.00 (0.00%)
MARKET · —
Price
Open
0.03
Prev close
0.03
Day high
0.03
Day low
0.03
Volume
18.75K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.28
Trailing performance
Returnvs SPY
1W
-6.90%
-5.5%
1M
-20.59%
-24.3%
3M
+50.00%
+46.9%
6M
+145.45%
+134.4%
YTD
+3.85%
-8.4%
1Y
-52.63%
-72.6%
3Y
-96.53%
-170.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.03
-3.23% from price
SMA 20
0.03
-8.47% from price
SMA 50
0.03
-18.33% from price
SMA 100
0.02
+12.41% from price
SMA 200
0.03
-0.15% from price
EMA 12
0.03
-4.35% from price
EMA 26
0.03
-8.83% from price
EMA 50
0.03
-8.10% from price
RSI (14)
45.0
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.01
25.40% of price
Realised vol 30D
184.7%
Annualised
Bollinger upper
0.03
20, 2σ
Bollinger lower
0.03
20, 2σ
50 / 200 cross
Golden
0.03 vs 0.03
Trend bias
Below 200
-0.15%
Risk profile
Beta vs SPY
6.97
More volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
184.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.5%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.01
25.40% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.